On or around 10/05/2017 (Ongoing date of last review)
Filing Date: January 31, 2017
According to the law firm press release, the complaint alleges that the Registration Statement and Prospectus issued in connection with the Initial Public Offering failed to disclose material information, including that ReWalk was unprepared and/or unable to comply with “special controls” requirements or to provide the U.S. Food and Drug Administration with a postmarket surveillance study as required by the FDA for the Company to maintain ongoing sales of its products.
Company & Securities Information
Defendant: ReWalk Robotics Ltd.
Industry: Medical Equipment & Supplies
Ticker Symbol: RWLK
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Qian Deng, et al. v. ReWalk Robotics Ltd., et al.
COURT: D. Massachusetts
DOCKET #: 17-CV-10169
JUDGE: Hon. F. Dennis Saylor, IV
DATE FILED: 01/31/2017
CLASS PERIOD START: 09/12/2014
CLASS PERIOD END: 01/31/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Block & Leviton LLP 155 Federal Street, Suite 1303, Block & Leviton LLP, MA 02110 (617) 398-5600 (617) 507-6020 ·
Gardy & Notis, LLP 501 Fifth Avenue, Suite 1408, Gardy & Notis, LLP, NY 10017 212-905-0509 212-905-0508 ·